{"id":56110,"date":"2025-04-24T01:52:54","date_gmt":"2025-04-24T01:52:54","guid":{"rendered":"https:\/\/prosfunds.com\/?p=56110"},"modified":"2025-04-24T01:53:02","modified_gmt":"2025-04-24T01:53:02","slug":"edwards-lifesciences-corporation-ew-q1-2025-earnings-call-transcript","status":"publish","type":"post","link":"https:\/\/prosfunds.com\/?p=56110","title":{"rendered":"Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript"},"content":{"rendered":"
\n

Edwards Lifesciences Corporation (NYSE:EW<\/span>) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET<\/p>\n

Company Participants<\/strong><\/p>\n

Mark Wilterding – SVP, Global Finance
Bernard Zovighian – CEO
Scott Ullem – CFO
Daveen Chopra – Global Leader, TMTT
Larry Wood – Global Group President, TAVR and Surgical<\/p>\n

Conference Call Participants<\/strong><\/p>\n

Larry Biegelsen – Wells Fargo
David Roman – Goldman Sachs
Travis Steed – Bank of America
Robbie Marcus – JPMorgan
Vijay Kumar – Evercore ISI
Matt Taylor – Jefferies
Joanne Wuensch – Citibank
Pito Chickering – Deutsche Bank
Chris Pasquale – Nephron
Patrick Wood – Morgan Stanley<\/p>\n

Operator<\/strong><\/p>\n

Greetings, and welcome to the Edwards Lifesciences First Quarter 2025 Results. [Operator Instructions] As a reminder, this conference is being recorded.<\/p>\n

It is now my pleasure to introduce you to your host, Mark Wilterding, Senior Vice President, Global Finance. Thank you, Mark. You may begin.<\/p>\n

Mark Wilterding<\/strong><\/p>\n

Thanks, Alicia, and thank you, everyone, for joining us this afternoon. With me on today’s call is our CEO, Bernard Zovighian, and our CFO, Scott Ullem. Also joining us for the Q&A portion of the call will be Larry Wood, our Global Group President of TAVR and Surgical; Daveen Chopra, our Global Leader of TMTT; and Wayne Markowitz, our Global Leader of Surgical.<\/p>\n

Just after the close of regular trading, Edwards Lifesciences released first quarter 2025 financial results. During today’s call, management will discuss those results included in the press release and accompanying financial schedules and then use the remainder of time for Q&A.<\/p>\n

Please note that, management will be making forward-looking statements that are based on estimates, assumptions and projections. These statements speak only as of the date on which they were made and Edwards does not undertake any obligation to update them after today.<\/p>\n

Additionally, the statements involve risks and uncertainties that could cause actual<\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Edwards Lifesciences Corporation (NYSE:EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Company Participants Mark Wilterding – SVP, Global FinanceBernard Zovighian – CEOScott Ullem – CFODaveen Chopra – Global Leader, TMTTLarry Wood – Global Group President, TAVR and Surgical Conference Call Participants Larry Biegelsen – Wells FargoDavid Roman – Goldman SachsTravis Steed […]<\/p>\n","protected":false},"author":1,"featured_media":3613,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[38],"tags":[],"class_list":{"0":"post-56110","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news"},"yoast_head":"\nEdwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript | Prosfunds<\/title>\n<meta name=\"description\" content=\"Edwards Lifesciences Corporation (NYSE:EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Company Participants Mark Wilterding - SVP, Global\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prosfunds.com\/?p=56110\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript | Prosfunds\" \/>\n<meta property=\"og:description\" content=\"Edwards Lifesciences Corporation (NYSE:EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Company Participants Mark Wilterding - SVP, Global\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prosfunds.com\/?p=56110\" \/>\n<meta property=\"og:site_name\" content=\"Prosfunds\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-24T01:52:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-24T01:53:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/prosfunds.com\/?p=56110#article\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/?p=56110\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\"},\"headline\":\"Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript\",\"datePublished\":\"2025-04-24T01:52:54+00:00\",\"dateModified\":\"2025-04-24T01:53:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/prosfunds.com\/?p=56110\"},\"wordCount\":302,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/prosfunds.com\/?p=56110#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/prosfunds.com\/?p=56110\",\"url\":\"https:\/\/prosfunds.com\/?p=56110\",\"name\":\"Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript | Prosfunds\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/#website\"},\"datePublished\":\"2025-04-24T01:52:54+00:00\",\"dateModified\":\"2025-04-24T01:53:02+00:00\",\"description\":\"Edwards Lifesciences Corporation (NYSE:EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Company Participants Mark Wilterding - SVP, Global\",\"breadcrumb\":{\"@id\":\"https:\/\/prosfunds.com\/?p=56110#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/prosfunds.com\/?p=56110\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/prosfunds.com\/?p=56110#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/prosfunds.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/prosfunds.com\/#website\",\"url\":\"https:\/\/prosfunds.com\/\",\"name\":\"Funding Factories\",\"description\":\"Latest Finance News and Updates\",\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/prosfunds.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/prosfunds.com\/#organization\",\"name\":\"Funding Factories\",\"url\":\"https:\/\/prosfunds.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"width\":780,\"height\":140,\"caption\":\"Funding Factories\"},\"image\":{\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/prosfunds.com\"],\"url\":\"https:\/\/prosfunds.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript | Prosfunds","description":"Edwards Lifesciences Corporation (NYSE:EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Company Participants Mark Wilterding - SVP, Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prosfunds.com\/?p=56110","og_locale":"en_US","og_type":"article","og_title":"Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript | Prosfunds","og_description":"Edwards Lifesciences Corporation (NYSE:EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Company Participants Mark Wilterding - SVP, Global","og_url":"https:\/\/prosfunds.com\/?p=56110","og_site_name":"Prosfunds","article_published_time":"2025-04-24T01:52:54+00:00","article_modified_time":"2025-04-24T01:53:02+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","type":"image\/png"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prosfunds.com\/?p=56110#article","isPartOf":{"@id":"https:\/\/prosfunds.com\/?p=56110"},"author":{"name":"News Room","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6"},"headline":"Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript","datePublished":"2025-04-24T01:52:54+00:00","dateModified":"2025-04-24T01:53:02+00:00","mainEntityOfPage":{"@id":"https:\/\/prosfunds.com\/?p=56110"},"wordCount":302,"commentCount":0,"publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/prosfunds.com\/?p=56110#respond"]}]},{"@type":"WebPage","@id":"https:\/\/prosfunds.com\/?p=56110","url":"https:\/\/prosfunds.com\/?p=56110","name":"Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript | Prosfunds","isPartOf":{"@id":"https:\/\/prosfunds.com\/#website"},"datePublished":"2025-04-24T01:52:54+00:00","dateModified":"2025-04-24T01:53:02+00:00","description":"Edwards Lifesciences Corporation (NYSE:EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Company Participants Mark Wilterding - SVP, Global","breadcrumb":{"@id":"https:\/\/prosfunds.com\/?p=56110#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prosfunds.com\/?p=56110"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/prosfunds.com\/?p=56110#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/prosfunds.com\/"},{"@type":"ListItem","position":2,"name":"Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript"}]},{"@type":"WebSite","@id":"https:\/\/prosfunds.com\/#website","url":"https:\/\/prosfunds.com\/","name":"Funding Factories","description":"Latest Finance News and Updates","publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prosfunds.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/prosfunds.com\/#organization","name":"Funding Factories","url":"https:\/\/prosfunds.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","width":780,"height":140,"caption":"Funding Factories"},"image":{"@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","caption":"News Room"},"sameAs":["https:\/\/prosfunds.com"],"url":"https:\/\/prosfunds.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/56110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=56110"}],"version-history":[{"count":1,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/56110\/revisions"}],"predecessor-version":[{"id":56111,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/56110\/revisions\/56111"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/media\/3613"}],"wp:attachment":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=56110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=56110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=56110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}